| [123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor R Djaldetti, BI Nageris, M Lorberboym, TA Treves, E Melamed, E Yaniv Journal of neural transmission 115, 469-472, 2008 | 34 | 2008 |
| [123]-FP-CIT SPELT imaging of dopamine transporters in patients with recurrent sudden falls R Djaldetti, M Lorberboym, S Yust-Katz, I Ziv, E Melamed MOVEMENT DISORDERS 22, S149-S149, 2007 | | 2007 |
| [123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease M Lorberboym, TA Treves, E Melamed, Y Lampl, M Hellmann, R Djaldetti Movement disorders: official journal of the Movement Disorder Society 21 (4 …, 2006 | 154 | 2006 |
| [I-123]-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism R Djaldetti, Y Lampl, E Melamed, M Lorberboym MOVEMENT DISORDERS 19, S332-S333, 2004 | | 2004 |
| 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism M Lorberboym, R Djaldetti, E Melamed, M Sadeh, Y Lampl Journal of Nuclear Medicine 45 (10), 1688-1693, 2004 | 119 | 2004 |
| 123I-FP-CIT SPECT imaging of dopamine transporters in patients with recurrent sudden falls: are such falls a distinct entity? R Djaldetti, TA Treves, I Ziv, E Melamed, M Lorberboym Journal of nuclear medicine technology 35 (4), 232-236, 2007 | 4 | 2007 |
| 15.14 Validation of the freezing of gait questionnaire (FOG-Q) in Parkinson's disease N Giladi, Y Tal, R Meiron, O Rasco, DJ Brooks, E Melamed, WH Oertel, ... Gait & Posture 21, S94, 2005 | 3 | 2005 |
| 2.7. 4 ADULT AUTOLOGOUS STEM CELLS: POTENTIAL DISEASE-MODIFYING STRATEGY FOR PARKINSON'S DISEASE E Melamed Parkinsonism and Related Disorders, S84-S85, 2012 | | 2012 |
| 3.020 DJ-1 BASED PEPTIDE AS A NOVEL NEUROPROTECTIVE STRATEGY IN PARKINSON'S DISEASE N Lev, Y Barhum, T Ben-Zur, E Melamed, D Offen Parkinsonism and Related Disorders, S174, 2012 | | 2012 |
| 6-hydroxydopamine affects proteasome activity in the PC12 cell line H Elkon, E Melamed, D Offen MOVEMENT DISORDERS 17, S59-S59, 2002 | | 2002 |
| 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease H Elkon, E Melamed, D Offen Cellular and molecular neurobiology 21, 771-781, 2001 | 75 | 2001 |
| A comparative randomised study of rasagiline versus placebo or entacapone as adjunct to levodopa in Parkinson's disease (PD) patients with motor fluctuations (the LARGO study) O Rascol, DJ Brooks, E Melamed, W Oertel, W Poewe, F Stocchi, ... Neurology 62 (7), A346-A346, 2004 | 18 | 2004 |
| A comparative study of rasagiline versus placebo or entacapone as adjunt to levodopa in Parkinson's disease (PD) patients with motor fluctuations (the LARGO Study) O Rascol, DJ Brooks, E Melamed, WH Oertel, W Poewe, F Stocchi, ... Movement Disorders 19 (SUPPL 9), S200-S201, 2004 | | 2004 |
| A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease Parkinson Study Group Arch Neurol 51, 342-347, 1994 | 47 | 1994 |
| A DJ-1 based peptide attenuates dopaminergic degeneration in mice models of Parkinson's disease via enhancing Nrf2 N Lev, Y Barhum, T Ben-Zur, I Aharony, L Trifonov, N Regev, E Melamed, ... PLoS One 10 (5), e0127549, 2015 | 45 | 2015 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ... New England Journal of Medicine 361 (13), 1268-1278, 2009 | 1054 | 2009 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in … O Rascol, CJ Fitzer-Attas, R Hauser, J Jankovic, A Lang, JW Langston, ... The Lancet Neurology 10 (5), 415-423, 2011 | 268 | 2011 |
| A low molecular weight copper chelator crosses the blood–brain barrier and attenuates experimental autoimmune encephalomyelitis D Offen, Y Gilgun‐Sherki, Y Barhum, M Benhar, L Grinberg, R Reich, ... Journal of neurochemistry 89 (5), 1241-1251, 2004 | 153 | 2004 |
| A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines D Tanne, U Goldbourt, S Koton, E Grossman, N Koren-Morag, MS Green, ... IMAJ-RAMAT GAN- 8 (1), 3, 2006 | 64 | 2006 |
| A Novel Brain-Targeted Antioxidant (AD4) Attenuates Haloperidol-Induced Abnormal Movement in Rats:: Implications for Tardive Dyskinesia O Sadan, M Bahat-Stromza, Y Gilgun-Sherki, D Atlas, E Melamed, D Offen Clinical neuropharmacology 28 (6), 285-288, 2005 | 30 | 2005 |
